Journal
NATURE REVIEWS GENETICS
Volume 15, Issue 7, Pages 445-451Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrg3742
Keywords
-
Categories
Funding
- US National Institutes of Health [R01 EY022975]
Ask authors/readers for more resources
Clinical gene therapy has been increasingly successful owing both to an enhanced molecular understanding of human disease and to progressively improving gene delivery technologies. Among these technologies, delivery vectors based on adeno-associated viruses (AAVs) have emerged as safe and effective and, in one recent case, have led to regulatory approval. Although shortcomings in viral vector properties will render extension of such successes to many other human diseases challenging, new approaches to engineer and improve AAV vectors and their genetic cargo are increasingly helping to overcome these barriers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available